Literature DB >> 20007690

MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes.

Hitoo Nishi1, Koh Ono, Yoshitaka Iwanaga, Takahiro Horie, Kazuya Nagao, Genzou Takemura, Minako Kinoshita, Yasuhide Kuwabara, Rieko Takanabe Mori, Koji Hasegawa, Toru Kita, Takeshi Kimura.   

Abstract

MicroRNAs (miRNAs or miRs) are small, non-coding RNAs that modulate mRNA stability and post-transcriptional translation. A growing body of evidence indicates that specific miRNAs can affect the cellular function of cardiomyocytes. In the present study, miRNAs that are highly expressed in the heart were overexpressed in neonatal rat ventricular myocytes, and cellular ATP levels were assessed. As a result, miR-15b, -16, -195, and -424, which have the same seed sequence, the most critical determinant of miRNA targeting, decreased cellular ATP levels. These results suggest that these miRNAs could specifically down-regulate the same target genes and consequently decrease cellular ATP levels. Through a bioinformatics approach, ADP-ribosylation factor-like 2 (Arl2) was identified as a potential target of miR-15b. It has already been shown that Arl2 localizes to adenine nucleotide transporter 1, the exchanger of ADP/ATP in mitochondria. Overexpression of miR-15b, -16, -195, and -424 suppressed the activity of a luciferase reporter construct fused with the 3'-untranslated region of Arl2. In addition, miR-15b overexpression decreased Arl2 mRNA and protein expression levels. The effects of Arl2 siRNA on cellular ATP levels were the same as those of miR-15b, and the expression of Arl2 could restore ATP levels reduced by miR-15b. A loss-of-function study of miR-15b resulted in increased Arl2 protein and cellular ATP levels. Electron microscopic analysis revealed that mitochondria became degenerated in cardiomyocytes that had been transduced with miR-15b and Arl2 siRNA. The present results suggest that miR-15b may decrease mitochondrial integrity by targeting Arl2 in the heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007690      PMCID: PMC2836096          DOI: 10.1074/jbc.M109.082610

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Transcription of the adenine nucleotide translocase isoforms in various types of tissues in the rat.

Authors:  A Dörner; M Olesch; S Giessen; M Pauschinger; H P Schultheiss
Journal:  Biochim Biophys Acta       Date:  1999-02-04

2.  Tissue heterogeneity of the mammalian mitochondrial proteome.

Authors:  D Thor Johnson; Robert A Harris; Stephanie French; Paul V Blair; Jinsam You; Kerry G Bemis; Mu Wang; Robert S Balaban
Journal:  Am J Physiol Cell Physiol       Date:  2006-08-23       Impact factor: 4.249

3.  A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator.

Authors:  B H Graham; K G Waymire; B Cottrell; I A Trounce; G R MacGregor; D C Wallace
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

4.  The SUMO protease SENP5 is required to maintain mitochondrial morphology and function.

Authors:  Rodolfo Zunino; Astrid Schauss; Peter Rippstein; Miguel Andrade-Navarro; Heidi M McBride
Journal:  J Cell Sci       Date:  2007-03-06       Impact factor: 5.285

5.  miR-15 and miR-16 induce apoptosis by targeting BCL2.

Authors:  Amelia Cimmino; George Adrian Calin; Muller Fabbri; Marilena V Iorio; Manuela Ferracin; Masayoshi Shimizu; Sylwia E Wojcik; Rami I Aqeilan; Simona Zupo; Mariella Dono; Laura Rassenti; Hansjuerg Alder; Stefano Volinia; Chang-Gong Liu; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-15       Impact factor: 11.205

6.  A fourth ADP/ATP carrier isoform in man: identification, bacterial expression, functional characterization and tissue distribution.

Authors:  Vincenza Dolce; Pasquale Scarcia; Domenico Iacopetta; Ferdinando Palmieri
Journal:  FEBS Lett       Date:  2005-01-31       Impact factor: 4.124

7.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

8.  MicroRNAs play an essential role in the development of cardiac hypertrophy.

Authors:  Danish Sayed; Chull Hong; Ieng-Yi Chen; Jacqueline Lypowy; Maha Abdellatif
Journal:  Circ Res       Date:  2007-01-18       Impact factor: 17.367

9.  Mitochondrial abnormalities in myocardium of dogs with chronic heart failure.

Authors:  H N Sabbah; V Sharov; J M Riddle; T Kono; M Lesch; S Goldstein
Journal:  J Mol Cell Cardiol       Date:  1992-11       Impact factor: 5.000

10.  Up-regulation of nuclear and mitochondrial genes in the skeletal muscle of mice lacking the heart/muscle isoform of the adenine nucleotide translocator.

Authors:  D G Murdock; B E Boone; L A Esposito; D C Wallace
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

View more
  63 in total

1.  MicroRNAs: Novel Regulators of the Heart.

Authors:  Junjie Xiao; Yi-Han Chen
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

2.  Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction.

Authors:  Walter A Baseler; Erinne R Dabkowski; Courtney L Williamson; Tara L Croston; Dharendra Thapa; Matthew J Powell; Trust T Razunguzwa; John M Hollander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

3.  MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1.

Authors:  Aránzazu Chamorro-Jorganes; Elisa Araldi; Luiz O F Penalva; Devraj Sandhu; Carlos Fernández-Hernando; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 4.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

Review 5.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 6.  MicroRNAs in cardiovascular ageing.

Authors:  Timon Seeger; Reinier A Boon
Journal:  J Physiol       Date:  2015-07-05       Impact factor: 5.182

Review 7.  Developing miRNA therapeutics for cardiac repair in ischemic heart disease.

Authors:  Kai Zhu; Dingqian Liu; Hao Lai; Jun Li; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

8.  Plasmids for variable expression of proteins targeted to the mitochondrial matrix or intermembrane space.

Authors:  Laura E Newman; Cara Schiavon; Richard A Kahn
Journal:  Cell Logist       Date:  2016-10-13

9.  A positive role of microRNA-15b on regulation of osteoblast differentiation.

Authors:  S Vimalraj; Nicola C Partridge; N Selvamurugan
Journal:  J Cell Physiol       Date:  2014-09       Impact factor: 6.384

10.  Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.

Authors:  N M A White; T-F F Chow; S Mejia-Guerrero; M Diamandis; Y Rofael; H Faragalla; M Mankaruous; M Gabril; A Girgis; G M Yousef
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.